array:18 [ "pii" => "S0210570522000784" "issn" => "02105705" "doi" => "10.1016/j.gastrohep.2022.02.004" "estado" => "S300" "fechaPublicacion" => "2022-11-01" "aid" => "1920" "copyright" => "Elsevier España, S.L.U." "documento" => "article" "crossmark" => 1 "subdocumento" => "rev" "cita" => "Gastroenterol Hepatol. 2022;45:715-23" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review</span>" "titulo" => "Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "715" "paginaFinal" => "723" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tratamiento de ascitis refractaria: estrategias actuales y nuevo panorama de los betabloqueadores no selectivos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 1413 "Ancho" => 2508 "Tamanyo" => 424691 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">The effects of nonselective beta-blockers on the therapeutic window in cirrhosis. Beta-blockers have no clear effects in early cirrhosis without ascites or in end-stage cirrhosis, aspects that mark the upper and lower limits of the therapeutic window. The onset of hyperdynamic circulation, with the development of sodium and water retention and ascites formation, reflects an adaptive response to peripheral vasodilatation and effective hypovolemia. However, as cirrhosis progresses, the cardiovascular response eventually loses its compensatory capacity. At this stage, previous evidence suggested that the hemodynamic effects of beta-blockers in reducing blood pressure and cardiac output may actually result in decreased survival in these patients. PRA: plasma renin activity, NE: norepinephrine, ADH: antidiuretic hormone.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "David Vidal González, Karla Paola Pérez López, Saúl André Vera Nungaray, Luis Guillermo Moreno Madrigal" "autores" => array:4 [ 0 => array:2 [ "nombre" => "David" "apellidos" => "Vidal González" ] 1 => array:2 [ "nombre" => "Karla Paola" "apellidos" => "Pérez López" ] 2 => array:2 [ "nombre" => "Saúl André" "apellidos" => "Vera Nungaray" ] 3 => array:2 [ "nombre" => "Luis Guillermo" "apellidos" => "Moreno Madrigal" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570522000784?idApp=UINPBA00004N" "url" => "/02105705/0000004500000009/v1_202211031708/S0210570522000784/v1_202211031708/en/main.assets" ]
Información de la revista
Vol. 45. Núm. 9.
Páginas 715-723 (noviembre 2022)
Vol. 45. Núm. 9.
Páginas 715-723 (noviembre 2022)
Review
Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers
Tratamiento de ascitis refractaria: estrategias actuales y nuevo panorama de los betabloqueadores no selectivos
David Vidal González, Karla Paola Pérez López, Saúl André Vera Nungaray, Luis Guillermo Moreno Madrigal
Información del artículo
Opciones para acceder a los textos completos de la publicación Gastroenterología y Hepatología
Suscriptor
Suscribirse
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
E-mail